COGENTIN

This brand name is authorized in Singapore, United States

Active ingredients

The drug COGENTIN contains one active pharmaceutical ingredient (API):

1 Benzatropine UNII WMJ8TL7510 - BENZTROPINE MESYLATE

Benzatropine possesses both anticholinergic and antihistaminic effects, although only the former have been established as therapeutically significant in the management of parkinsonism. Read about Benzatropine

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
COGENTIN Solution for injection	FDA, National Drug Code (US)	MPI, US: SPL/Old

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
N04AC01	Benzatropine	N Nervous system → N04 Anti-parkinson drugs → N04A Anticholinergic agents → N04AC Ethers of tropine or tropine derivatives
Discover more medicines within N04AC01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: SG	Health Sciences Authority	Identifier(s): 05387P
Country: US	FDA, National Drug Code	Identifier(s): 76478-611